📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Serine-arginine protein kinase 1 (SRPK1) inhibition as a potential novel targeted therapeutic strategy in prostate cancer. (2015)

First Author: Mavrou A

Attributed to: Functional significance of VEGF regulation by SRPK1 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/onc.2014.360

PubMed Identifier: 25381816

Publication URI: http://europepmc.org/abstract/MED/25381816

Type: Journal Article/Review

Volume: 34

Parent Publication: Oncogene

Issue: 33

ISSN: 0950-9232